FairValueLabs Valuation System Value Investment
PG

The Procter & Gamble Company (PG) Stock Analysis — Fair Value, Risk & Moat Rating

NYQ · Consumer Defensive · Household & Personal Products

$142.85 Fairly Valued 0.53 (0.4%) As of Apr 22, 2026 Not a buy/sell recommendation. See disclaimer.
Overall Verdict Safe Zone
5.32
Altman Z-ScoreSafe Zone
$127.26
Fair ValueFairly Valued (-12.3%)
3.7
Moat RatingSolid moat · eroding
TL;DR · Audit Summary

Is The Procter & Gamble Company a safe investment right now?

The Procter & Gamble Company's Altman Z-Score of 5.32 places it in the safe zone. Our fair value estimate is $127.26 (Fairly Valued). Moat rating: 3.7/5 stars.

Price Chart · PG
Section 01 · Financial Health

Could The Procter & Gamble Company go bankrupt? Altman Z-Score analysis

5.32

Z-Score of 5.32 is above 3.0, indicating the company is financially healthy by this metric.

  • Below 1.8 — Distress Zone (high bankruptcy risk)
  • 1.8 to 3.0 — Gray Zone (elevated uncertainty)
  • Above 3.0 — Safe Zone (financially healthy)

What drives PG's Z-Score?

Altman Z-Score components for PG
ComponentFormulaValueWeightContribution
A · Working Capital / Total AssetsWC / TA-0.08521.2-0.1
B · Retained Earnings / Total AssetsRE / TA1.03791.41.45
C · EBIT / Total AssetsEBIT / TA0.16833.30.56
D · Market Cap / Total LiabilitiesMCap / TL4.5760.62.75
E · Revenue / Total AssetsRev / TA0.6731.00.67

How has PG's financial health changed over time?

3.0 Safe1.8 Distress0.01.53.14.66.12022202320242025
PG Z-Score history
YearZ-ScoreZone
20225.28Safe
20235.15Safe
20245.34Safe
20255.32Safe

Source: Calculated from PG's latest 10-K filing on SEC EDGAR.

Section 02 · Fair Value Estimate

What is The Procter & Gamble Company actually worth?

FVL Fair Value$127.26
vs
Market Price$142.85
Fairly Valued -12.3% Stock trades 12.2% above our estimated fair value of $127.26.

How we calculated this

FVL Valuation Model
InputValueSource
Predicted EPS (α)$7.07Proprietary blend of reported actuals (2Q actual) + analyst consensus, weighted by α
Last Year EPS$6.51Annual report (SEC EDGAR)
Analyst Consensus EPS (This Year)$6.9522 analysts consensus
Trailing P/E21.1xCurrent market pricing
Fair P/E (β discount)18.0xTrailing PE adjusted by value discount factor β, hard-capped
Earnings Trend (γ)GrowingDirectional signal: predicted vs trailing EPS

Wall Street Reference: Analyst consensus target price is $164.00 (22 analysts). This is shown for reference only and is not used in our valuation model.

Source: Earnings data from SEC EDGAR filings. Market data via Yahoo Finance.

Section 03 · Competitive Moat

Does The Procter & Gamble Company have a durable competitive advantage?

★★★½☆
Solid moat · eroding

Moat rating: 3.7/5.

What makes up PG's moat score?

ROIC Stability

★★★★☆

ROIC variability over the past decade. Score: 4/5.

Gross Margin Trend

★★★★☆

Gross margin trajectory over the past decade. Score: 4/5.

Switching Costs

★★★☆☆

Estimated customer lock-in based on margin level. Score: 3/5.

How stable is PG's return on invested capital?

0%-5%4%12%21%30%2022202320242025
PG ROIC history
YearROICTrend
202223.9%
202323.7%Stable
202424.0%Stable
202524.6%Stable

Source: ROIC calculated from SEC EDGAR filings.

Section 04 · Dividend Safety

Is The Procter & Gamble Company's dividend safe?

A Dividend Safety Grade
Yield2.9%
Payout Ratio61.9%
Consecutive Years65
5Y Growth Rate-20.8%

Can The Procter & Gamble Company afford its dividend?

Payout ratio is 61.9%. FCF covers the dividend 1.5x. 65 consecutive years of payments.

Section 05 · Financial Summary

The Procter & Gamble Company's key financial metrics

PG financial summary
MetricLatest1Y Ago3Y AgoTrend
Revenue $84.3B $84.0B $80.2B Rising
Net Income $16.0B $14.9B $14.7B Rising
Free Cash Flow $14.0B $16.5B $13.6B Stable
Gross Margin 51.2% 51.4% 47.4% Rising
Section 06 · Lab Signals

Recent events that affect our PG analysis

EARNINGS

PG earnings report scheduled

Lab Impact

Upcoming report. Consensus EPS estimate: $1.56. Revenue estimate: $20.52B. Our current Fair Value: $127.26 — a significant beat or miss could shift this estimate.

ANALYST

PG analyst consensus: 58% bullish (14 of 24 analysts)

Lab Impact

5 Strong Buy, 9 Buy, 9 Hold, 0 Sell, 1 Strong Sell. Consensus target: $164.00 (14.8% upside). Compare with our independent Fair Value: $127.26.

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

PG filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

DIVIDEND

PG paid $1.0570/share dividend

Lab Impact

Dividend Safety Grade: A. Payout ratio: 61.9%.

EARNINGS

PG beat EPS estimates by 1.2%

Lab Impact

Reported EPS: $1.88 vs estimate $1.86. Earnings strength supports our Fair Value of $127.26 (10.9% below current price).

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

PG beat EPS estimates by 4.9%

Lab Impact

Reported EPS: $1.99 vs estimate $1.90. Earnings strength supports our Fair Value of $127.26 (10.9% below current price).

FILING

PG filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

PG paid $1.0570/share dividend

Lab Impact

Dividend Safety Grade: A. Payout ratio: 61.9%.

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

PG filed annual report (10-K)

Lab Impact

Annual filing with full-year financials. Our Altman Z-Score, Moat, and Fair Value models are derived from this data. View on SEC EDGAR →

EARNINGS

PG beat EPS estimates by 4.1%

Lab Impact

Reported EPS: $1.48 vs estimate $1.42. Earnings strength supports our Fair Value of $127.26 (10.9% below current price).

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

PG paid $1.0570/share dividend

Lab Impact

Dividend Safety Grade: A. Payout ratio: 61.9%.

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

EARNINGS

PG beat EPS estimates by 0.9%

Lab Impact

Reported EPS: $1.54 vs estimate $1.53. Earnings strength supports our Fair Value of $127.26 (10.9% below current price).

FILING

PG filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

PG paid $1.0570/share dividend

Lab Impact

Dividend Safety Grade: A. Payout ratio: 61.9%.

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

DIVIDEND

PG paid $1.0070/share dividend

Lab Impact

Dividend Safety Grade: A. Payout ratio: 61.9%.

EARNINGS

PG beat EPS estimates by 1.1%

Lab Impact

Reported EPS: $1.88 vs estimate $1.86. Earnings strength supports our Fair Value of $127.26 (10.9% below current price).

FILING

PG filed quarterly report (10-Q)

Lab Impact

Quarterly update with interim financials. May signal changes to earnings trajectory and balance sheet health. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

FILING

PG filed 8-K (material event)

Lab Impact

8-K filings disclose material events — acquisitions, leadership changes, or guidance revisions that may affect valuation. View on SEC EDGAR →

Section 07 · FAQ

Common questions about The Procter & Gamble Company

What is The Procter & Gamble Company stock price today?

The Procter & Gamble Company (PG) stock price is $142.85 as of the latest market close, traded on the NYSE exchange.

What does The Procter & Gamble Company do?

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care segments. It offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands; and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands.

What is The Procter & Gamble Company market cap?

The Procter & Gamble Company has a market capitalization of $333.80B, classifying it as a mega-cap stock in the Consumer Defensive sector.

What sector and industry is PG in?

The Procter & Gamble Company operates in the Consumer Defensive sector, specifically within the Household & Personal Products industry. It trades on the NYSE under the ticker symbol PG.

Is PG stock overvalued or undervalued?

Based on our valuation model, The Procter & Gamble Company trades 12.2% above our fair value estimate — potentially overvalued.

  • FairValueLabs Fair Value: $127.26
  • Current Price: $142.85
  • Valuation Zone: Fairly Valued
What is PG stock forecast and analyst target price?

Based on 22 Wall Street analysts, the consensus price target for The Procter & Gamble Company is $164.00, implying upside of 14.8% from the current price.

  • Analyst High Target: $186.00
  • Analyst Low Target: $142.00

Note: Analyst targets are shown for reference and are not used in our valuation model.

Is The Procter & Gamble Company revenue and earnings growing?

Here are the analyst consensus growth estimates for The Procter & Gamble Company:

  • Revenue growth (current year est.): 2.7%
  • EPS growth (current year est.): 1.7%
  • Revenue growth (next year est.): 2.6%
  • EPS growth (next year est.): 4.1%
What are The Procter & Gamble Company's key financial metrics?
MetricLatestTrend
Revenue$84.3BRising
Net Income$16.0BRising
Free Cash Flow$14.0BStable
Gross Margin51.2%Rising
What is PG's P/E ratio?

The price-to-earnings ratio measures how much investors pay per dollar of earnings:

  • Trailing P/E (last 12 months): 21.1x
  • Forward P/E (next 12 months est.): 19.8x
  • FairValueLabs Fair P/E: 18.0x
How volatile is PG stock?

The Procter & Gamble Company has a beta of 0.40, meaning it is less volatile than the broader market. A beta above 1.0 indicates higher price swings relative to the S&P 500, while below 1.0 suggests more stability.

How much cash and debt does The Procter & Gamble Company have?

The Procter & Gamble Company's balance sheet shows:

  • Total Cash: $10.82B
  • Total Debt: $36.64B
  • Net Cash Position: $-25.81B

A positive net cash position means the company holds more cash than debt, reducing financial risk.

What is The Procter & Gamble Company's free cash flow?

The Procter & Gamble Company generated $13.25B in trailing twelve-month free cash flow (from $19.07B in operating cash flow). Free cash flow represents the cash available for dividends, buybacks, and debt reduction after all capital expenditures.

Does The Procter & Gamble Company pay a dividend, and is it safe?

Yes, The Procter & Gamble Company pays a regular dividend. Here are the key metrics:

  • Dividend Yield: 2.9%
  • Payout Ratio: 61.9%
  • Consecutive Years Paid: 65
  • 5-Year Dividend Growth: -20.8%
  • FairValueLabs Safety Grade: A
Is The Procter & Gamble Company at risk of going bankrupt?

The Procter & Gamble Company's Altman Z-Score is 5.32, placing it in the safe zone (above 3.0) — bankruptcy risk is low. The Z-Score uses five balance sheet ratios to predict bankruptcy probability within two years.

Does The Procter & Gamble Company have a durable competitive advantage?

The Procter & Gamble Company scores 3.7/5 stars (Solid moat · eroding) in our moat analysis:

  • ROIC Stability: 4/5
  • Gross Margin Trend: 4/5
  • Switching Costs: 3/5

A score above 3.5 suggests meaningful pricing power and a defensible market position.

What is PG's return on equity (ROE)?

The Procter & Gamble Company's return on equity is 31.6%. ROE measures how efficiently a company generates profits from shareholder equity. An ROE above 15% is generally considered strong, while below 10% may signal inefficiency.

How do I buy PG stock?

PG shares can be purchased through any brokerage account that provides access to the NYSE. Common steps:

  1. Open an account with a broker (e.g., Fidelity, Schwab, Interactive Brokers)
  2. Search for ticker symbol PG
  3. Place a market or limit order for your desired number of shares

This is not investment advice. Always do your own research before buying any stock.

Is PG a value stock or speculative?

FairValueLabs classifies The Procter & Gamble Company as Value Investment. It exhibits consistent profitability, reasonable valuation, and financial stability — characteristics of a traditional value investment.

Who is the CEO of The Procter & Gamble Company?

The current CEO of The Procter & Gamble Company is Mr. Shailesh G. Jejurikar.

What is PG's earnings per share (EPS)?

Earnings per share measures the company's profit allocated to each outstanding share:

  • Trailing EPS (last 12 months): $6.76
  • Forward EPS (next 12 months est.): $7.22
  • Analyst consensus EPS (this year): $6.95
  • Analyst consensus EPS (next year): $7.23

FairValueLabs Disclaimer

All valuations, scores, ratings, and classifications on this page are produced by the FairValueLabs internal valuation system. They do not represent actual market value, guaranteed outcomes, or professional investment advice. These are analytical estimates for educational and research purposes only.

This is not financial advice. All data is sourced from SEC EDGAR public filings. Always consult a qualified financial advisor before making investment decisions.

Last updated: Apr 22, 2026. Data sources: SEC EDGAR (financial statements), Yahoo Finance (market data, analyst consensus). Data may not reflect the most recent quarter.

PG analysis methodology: How we calculate fair value, Z-Scores, and moat ratings